Free Trial
Serge Belanger

Serge Belanger Analyst Performance

Senior Analyst at Needham & Company LLC

Serge Belanger is a stock analyst at Needham & Company LLC focused in the medical sector, covering 24 publicly traded companies. Over the past year, Serge Belanger has issued 80 stock ratings, including buy and hold recommendations. While full access to Serge Belanger's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Serge Belanger's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
205 Last 11 Years
Buy Recommendations
88.29% 181 Buy Ratings
Companies Covered
24 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy88.3%181 ratings
Hold11.7%24 ratings
Sell0.0%0 ratings

Out of 205 total stock ratings issued by Serge Belanger at Needham & Company LLC, the majority (88.3%) have been Buy recommendations, followed by 11.7% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
91.7% of companies on NASDAQ
22 companies
NYSE
4.2% of companies on NYSE
1 company
OTCMKTS
4.2% of companies on OTCMKTS
1 company

Serge Belanger, an analyst at Needham & Company LLC, currently covers 24 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
23 companies
95.8%
Manufacturing
1 company
4.2%

Serge Belanger of Needham & Company LLC specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
11 companies
45.8%
MED - DRUGS
9 companies
37.5%
MED PRODUCTS
2 companies
8.3%
PHARMACEUTICAL PREPARATIONS
1 company
4.2%
MED - GENERIC DRG
1 company
4.2%

About Serge Belanger

Serge Belanger joined Needham & Company in 2009, where he covers the Biotechnology sector. Prior to Needham, Serge worked as a research associate at Fulcrum Global Partners and Susquehanna International Group covering the biotech and specialty pharma healthcare sectors. Previously, Serge was part of Adolor Corporation, a biopharmaceutical company, as a senior research scientist, where he was involved with the discovery and development of novel opioid receptor targeted molecules and non-opioid pain therapeutics. Serge graduated from McGill University with a BSc, Biochemistry/Pharmacology, and an MSc, Pharmacology and Therapeutics. He obtained his MBA in Finance from the Stern School of Business at New York University.
Follow on LinkedIn

Serge Belanger's Ratings History at Needham & Company LLC

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Heron Therapeutics, Inc. stock logo
HRTX
Heron Therapeutics
6/2/2026Downgrade$0.45Hold
MANE
Veradermics
6/2/2026Initiated Coverage$101.96$136.00Buy
Oculis Holding AG stock logo
OCS
Oculis
6/1/2026Lower Price Target$22.70$38.00Buy
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
5/20/2026Reiterated Rating$13.77$23.00Buy
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
5/12/2026Boost Price Target$18.84$30.00Buy
Oculis Holding AG stock logo
OCS
Oculis
5/12/2026Boost Price Target$30.40$46.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
5/11/2026Boost Price Target$52.61$70.00Buy
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
5/8/2026Lower Price Target$56.00$78.00Buy
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
5/8/2026Reiterated Rating$24.03Hold
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
5/7/2026Reiterated Rating$24.17$36.00Buy
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
5/6/2026Lower Price Target$14.66$23.00Buy
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
5/6/2026Lower Price Target$8.86$16.00Buy
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
5/5/2026Reiterated Rating$18.77$32.00Buy
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
5/5/2026Reiterated Rating$9.71$18.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
5/5/2026Boost Price Target$77.20$102.00Buy
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
5/4/2026Downgrade$3.12Hold
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
5/1/2026Boost Price Target$25.49$32.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
4/30/2026Downgrade$26.66Hold
CorMedix Inc stock logo
CRMD
CorMedix
4/27/2026Boost Price Target$7.54$15.00Buy
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
3/30/2026Lower Price Target$18.52$32.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
3/25/2026Boost Price Target$17.14$36.00Buy
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
3/19/2026Reiterated Rating$36.30$56.00Buy
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
3/18/2026Boost Price Target$11.19$24.00Buy
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
3/9/2026Boost Price Target$61.46$80.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
3/5/2026Boost Price Target$34.52$54.00Buy
CorMedix Inc stock logo
CRMD
CorMedix
3/5/2026Lower Price Target$6.30$14.00Buy
Oculis Holding AG stock logo
OCS
Oculis
3/4/2026Boost Price Target$27.57$40.00Buy
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
3/3/2026Boost Price Target$2.94$5.00Buy
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
2/27/2026Lower Price Target$26.49$30.00Buy
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
2/27/2026Boost Price Target$42.23$58.00Buy
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
2/26/2026Boost Price Target$27.01$36.00Buy
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
2/26/2026Lower Price Target$44.01$54.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
2/25/2026Boost Price Target$70.10$85.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
2/25/2026Reiterated Rating$30.16$52.00Buy
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
2/23/2026Boost Price Target$18.68$25.00Buy
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
2/20/2026Lower Price Target$7.03$18.00Buy
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
2/18/2026Boost Price Target$36.41$48.00Buy
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
2/4/2026Reiterated Rating$31.90$42.00Buy
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
1/26/2026Boost Price Target$26.29$31.00Buy
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
1/9/2026Reiterated Rating$26.02$30.00Buy
Stranded On The Flood Plains of History (Ad)

The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar.tc pixel

Read Porter's full briefing and get the ticker names today
CorMedix Inc stock logo
CRMD
CorMedix
1/8/2026Lower Price Target$7.51$15.00Buy
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
1/8/2026Boost Price Target$48.78$56.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
1/6/2026Boost Price Target$15.66$32.00Buy
Evolus, Inc. stock logo
EOLS
Evolus
12/24/2025Reiterated Rating$6.81Hold
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
12/23/2025Boost Price Target$32.47$42.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
12/22/2025Boost Price Target$62.72$84.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
12/12/2025Reiterated Rating$60.77$72.00Buy
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
12/8/2025Reiterated Rating$15.95$20.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
12/4/2025Reiterated Rating$14.66$28.00Buy
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
11/18/2025Reiterated Rating$3.32Hold
CorMedix Inc stock logo
CRMD
CorMedix
11/12/2025Lower Price Target$11.17$16.00Buy
Oculis Holding AG stock logo
OCS
Oculis
11/11/2025Reiterated Rating$19.42$36.00Buy
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
11/7/2025Lower Price Target$24.23$34.00Buy
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
11/5/2025Boost Price Target$39.84$46.00Buy
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
11/4/2025Lower Price Target$6.86$18.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
11/4/2025Boost Price Target$25.22$52.00Buy
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
11/4/2025Reiterated Rating$41.12$55.00Buy
Collegium Pharmaceutical, Inc. stock logo
COLL
Collegium Pharmaceutical
10/28/2025Reiterated Rating$34.81$46.00Buy
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
10/28/2025Boost Price Target$24.95$30.00Buy
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
10/22/2025Reiterated Rating$24.26$36.00Buy
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
10/15/2025Boost Price Target$6.42$20.00Buy
Omeros Corporation stock logo
OMER
Omeros
10/15/2025Reiterated Rating$10.94Hold
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
10/1/2025Boost Price Target$11.11$20.00Buy
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
9/30/2025Lower Price Target$6.24$20.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
9/12/2025Reiterated Rating$13.60$28.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
9/2/2025Reiterated Rating$35.33$72.00Buy
Oculis Holding AG stock logo
OCS
Oculis
8/27/2025Initiated Coverage$17.53$36.00Buy
Omeros Corporation stock logo
OMER
Omeros
8/15/2025Reiterated Rating$4.12Hold
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
8/12/2025Upgrade$27.36$36.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
8/12/2025Boost Price Target$24.10$36.00Buy
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
8/8/2025Lower Price Target$7.30$22.00Buy
Heron Therapeutics, Inc. stock logo
HRTX
Heron Therapeutics
8/8/2025Lower Price Target$1.33$3.00Buy
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
8/7/2025Boost Price Target$15.36$22.00Buy
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
8/6/2025Lower Price Target$17.22$34.00Buy
Evolus, Inc. stock logo
EOLS
Evolus
8/6/2025Reiterated Rating$8.91$22.00Hold
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
8/5/2025Boost Price Target$12.00$15.00Buy
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
8/4/2025Reiterated Rating$8.73$17.00Buy
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
7/17/2025Downgrade$9.12$45.00Hold
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
6/25/2025Reiterated Rating$9.78$17.00Buy
CorMedix Inc stock logo
CRMD
CorMedix
6/24/2025Boost Price Target$16.56$20.00Buy
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
6/12/2025Reiterated Rating$20.50$40.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
5/28/2025Reiterated Rating$15.60$25.00Buy
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
5/23/2025Reiterated Rating$13.66$20.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
5/21/2025Reiterated Rating$17.02$25.00Buy
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
5/20/2025Reiterated Rating$6.49$24.00Buy
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
5/20/2025Reiterated Rating$13.25$36.00Buy
Omeros Corporation stock logo
OMER
Omeros
5/16/2025Reiterated Rating$3.95Hold
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
5/15/2025Lower Price Target$12.81$45.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
5/14/2025Reiterated Rating$30.61$72.00Buy
Verrica Pharmaceuticals Inc. stock logo
VRCA
Verrica Pharmaceuticals
5/14/2025Reiterated Rating$0.50Hold
Better than SpaceX? Grab this ticker instead. (Ad)

Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says 'The Final Phase of Elon's Master Plan' is about to trigger one of the biggest wealth transfers in market history. He's identified one ticker positioned to capture it - and it isn't SpaceX or Tesla. He's releasing the name for free, but the window is closing.tc pixel

Get the full details and the ticker name before access closes
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
5/13/2025Lower Price Target$35.85$55.00Buy
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
5/13/2025Reiterated Rating$40.18$66.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
5/12/2025Reiterated Rating$15.93$25.00Buy
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
5/9/2025Lower Price Target$24.90$30.00Buy
Evolus, Inc. stock logo
EOLS
Evolus
5/8/2025Reiterated Rating$11.80$22.00Buy
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
5/8/2025Lower Price Target$19.50$40.00Buy
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
5/7/2025Lower Price Target$12.03$36.00Buy
CorMedix Inc stock logo
CRMD
CorMedix
5/7/2025Boost Price Target$11.16$15.00Buy
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
5/7/2025Lower Price Target$0.98$4.00Buy
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
5/6/2025Boost Price Target$11.03$17.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
5/2/2025Reiterated Rating$42.92$72.00Buy
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
4/30/2025Reiterated Rating$40.18$66.00Buy
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
4/25/2025Reiterated Rating$0.88$5.00Buy
Heron Therapeutics, Inc. stock logo
HRTX
Heron Therapeutics
4/11/2025Reiterated Rating$1.82$4.00Buy
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
4/10/2025Reiterated Rating$6.77$15.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
4/10/2025Reiterated Rating$12.77$25.00Buy
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
4/10/2025Reiterated Rating$25.23Hold
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
4/9/2025Reiterated Rating$13.29$20.00Buy
Verrica Pharmaceuticals Inc. stock logo
VRCA
Verrica Pharmaceuticals
4/9/2025Reiterated Rating$0.58Hold
Evolus, Inc. stock logo
EOLS
Evolus
4/9/2025Reiterated Rating$9.36$22.00Buy
CorMedix Inc stock logo
CRMD
CorMedix
4/9/2025Reiterated Rating$6.79$12.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
4/8/2025Reiterated Rating$11.50$28.00Buy
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
4/8/2025Reiterated Rating$5.78$24.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
4/8/2025Reiterated Rating$35.99$72.00Buy
Esperion Therapeutics, Inc. stock logo
ESPR
Esperion Therapeutics
4/8/2025Reiterated Rating$1.20$5.00Buy
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
4/8/2025Reiterated Rating$12.68$60.00Buy
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
4/8/2025Reiterated Rating$15.86$42.00Buy
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
4/8/2025Reiterated Rating$22.91$32.00Buy
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
4/3/2025Reiterated Rating$16.60$20.00Buy
Omeros Corporation stock logo
OMER
Omeros
4/1/2025Reiterated Rating$8.27Hold
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
3/28/2025Lower Price Target$15.45$60.00Buy
CorMedix Inc stock logo
CRMD
CorMedix
3/26/2025Lower Price Target$7.34$12.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
3/26/2025Reiterated Rating$12.07$28.00Buy
Liquidia Corporation stock logo
LQDA
Liquidia
3/20/2025Boost Price Target$14.92$25.00Buy
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
3/19/2025Lower Price Target$6.56$24.00Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
3/13/2025Reiterated Rating$12.45$28.00Buy
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
3/11/2025Initiated Coverage$7.65$15.00Buy
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
3/10/2025Boost Price Target$4.30$25.00Buy
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
3/6/2025Reiterated Rating$14.40$90.00Buy
Evolus, Inc. stock logo
EOLS
Evolus
3/5/2025Reiterated Rating$14.35$22.00Buy
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
2/28/2025Boost Price Target$25.38$32.00Buy
Heron Therapeutics, Inc. stock logo
HRTX
Heron Therapeutics
2/28/2025Reiterated Rating$2.05$4.00Buy
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
2/27/2025Boost Price Target$42.37$66.00Buy
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
2/26/2025Reiterated Rating$12.20$20.00Buy
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
2/6/2025Reiterated Rating$46.44$72.00Buy
Evolus, Inc. stock logo
EOLS
Evolus
1/21/2025Reiterated Rating$13.87$22.00Buy
Omeros Corporation stock logo
OMER
Omeros
1/17/2025Reiterated Rating$9.18Hold
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
1/13/2025Boost Price Target$7.67$15.00Buy
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
1/13/2025Boost Price Target$20.64$30.00Buy